D
Daiqiang Li
Researcher at Central South University
Publications - 4
Citations - 2687
Daiqiang Li is an academic researcher from Central South University. The author has contributed to research in topics: Cancer & Anaplastic lymphoma kinase. The author has an hindex of 3, co-authored 3 publications receiving 2527 citations.
Papers
More filters
Journal ArticleDOI
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Klarisa Rikova,Ailan Guo,Qingfu Zeng,Anthony Possemato,Jian Yu,Herbert Haack,Julie Nardone,Kimberly Lee,Cynthia Reeves,Yu Li,Yerong Hu,Zhi-Ping Tan,Matthew P. Stokes,Laura Sullivan,Jeffrey Mitchell,Randy Wetzel,Joan MacNeill,Jian Min Ren,Jin Yuan,Corey E. Bakalarski,Judit Villén,Jon M. Kornhauser,Bradley L. Smith,Daiqiang Li,Xinmin Zhou,Steven P. Gygi,Ting-Lei Gu,Roberto D. Polakiewicz,John Rush,Michael J. Comb +29 more
TL;DR: By focusing on activated cell circuitry, the approach outlined here provides insight into cancer biology not available at the chromosomal and transcriptional levels and can be applied broadly across all human cancers.
Journal ArticleDOI
Analysis of Receptor Tyrosine Kinase ROS1-Positive Tumors in Non–Small Cell Lung Cancer: Identification of a FIG-ROS1 Fusion
Victoria Rimkunas,Katherine Crosby,Daiqiang Li,Yerong Hu,Meghan E. Kelly,Ting-Lei Gu,Jennifer S. Mack,Matthew Ren Silver,Xinmin Zhou,Herbert Haack +9 more
TL;DR: The ROS1 IHC assay described here is a valuable tool for identifying patients expressing mutant ROS1 and could be routinely applied in clinical practice to detect lung cancers that may be responsive to targeted therapies.
Journal ArticleDOI
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
Jian Yu,Susan E. Kane,Jiong Wu,Elisa Benedettini,Daiqiang Li,Cynthia Reeves,Gregory Innocenti,Randy Wetzel,Katherine Crosby,Alison Becker,Michelle Ferrante,Wan Cheung Cheung,Xiqiang Hong,Lucian R. Chirieac,Lynette M. Sholl,Herbert Haack,Bradley L. Smith,Roberto D. Polakiewicz,Yi Tan,Ting-Lei Gu,Massimo Loda,Xinmin Zhou,Michael J. Comb +22 more
TL;DR: This simple assay for detection of EGFR mutations in diagnostic human tissues provides a rapid, sensitive, specific, and cost-effective method to identify lung cancer patients responsive to EGFR-based therapies.
Journal ArticleDOI
FOXP1 and FOXO3a Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas
TL;DR: It is indicated that negative FOXP1 and FOXO3a expression are closely associated with the pathogenesis, clinicopathologic properties, and prognosis of GBC patients and may thus be biomarkers of G BC carcinogenesis, progression, and prediction.